KCNA3 and heart failure: Due to the formation of an active metabolite designated OR-1896 in the systemic and pulmonary hemodynamic field, Levosimendan, a calcium sensitizer, and potassium channel-opener, is valued by specialists in heart failure practitioners for its prolonged duration of effect (1, 5).